bf/NASDAQ:LBPH_icon.jpeg

COM:LONGBOARDPHARMA

Longboard Pharmaceuticals

  • Stock

USD

Last Close

59.77

22/11 21:00

Market Cap

1.44B

Beta: -

Volume Today

1.29M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
1.12M
-
1.17M
4.33%
1.16M
1.15%
average receivables
book value per share
3.14
-
7.17
128.41%
3.58
50.01%
0.00
99.95%
capex per share
-0.00
-
capex to depreciation
-16
-
capex to operating cash flow
0.00
-
capex to revenue
cash per share
3.27
-
7.41
126.50%
3.94
46.79%
0.00
99.95%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.00
-
0.01
117.89%
debt to equity
0.01
-
0.01
137.37%
dividend yield
earnings yield
-0.05
-
-0.39
671.39%
-0.77
95.43%
-0.00
99.95%
enterprise value
226.35M
-
4.50M
98.01%
45.88M
919.20%
137.03B
298,580.25%
enterprise value over ebitda
-15.72
-
-0.16
98.97%
-1.02
533.35%
-2.41K
235,638.43%
ev to operating cash flow
-65.76
-
-0.18
99.72%
-1.21
561.52%
ev to sales
free cash flow per share
-0.20
-
-1.72
743.14%
-2.22
29.37%
free cash flow yield
-0.01
-
-0.35
2,776.69%
-0.68
93.66%
graham net net
3.08
-
7.02
127.44%
3.41
51.43%
0.00
99.95%
graham number
7.75
-
17.62
127.25%
14.23
19.22%
0.01
99.93%
income quality
0.24
-
0.89
271.82%
0.87
2.54%
intangibles to total assets
0
-
0
0
0
interest coverage
-53.52
-
interest debt per share
0.04
-
0.09
152.87%
inventory turnover
invested capital
0.01
-
0.01
137.37%
market cap
281.67M
-
70.32M
75.03%
55.91M
20.49%
137.04B
244,999.17%
net current asset value
52.23M
-
102.75M
96.75%
60.69M
40.94%
40.45M
33.36%
net debt to ebitda
3.84
-
2.36
38.45%
0.22
90.53%
0.25
12.72%
net income per share
-0.85
-
-1.92
126.09%
-2.51
30.55%
-0.00
99.90%
operating cash flow per share
-0.20
-
-1.71
742.59%
-2.22
29.45%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.26
-
-0.25
0.59%
-0.61
139.74%
-1.07
75.91%
revenue per share
roe
-0.27
-
-0.27
1.02%
-0.70
161.18%
-1.33
89.70%
roic
-0.27
-
-0.27
1.86%
-0.70
162.23%
-1.39
98.75%
sales general and administrative to revenue
shareholders equity per share
3.14
-
7.17
128.41%
3.58
50.01%
0.00
99.95%
stock based compensation to revenue
tangible asset value
53.10M
-
103.32M
94.57%
61.47M
40.51%
40.92M
33.43%
tangible book value per share
3.14
-
7.17
128.41%
3.58
50.01%
0.00
99.95%
working capital
52.23M
-
102.94M
97.10%
61.07M
40.67%
40.45M
33.77%

All numbers in USD (except ratios and percentages)